Back to Journals » OncoTargets and Therapy » Volume 4

Review

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer

      
Total article views   HTML views PDF downloads Totals
12,218 Dovepress* 10,058+ 1,707 11,765
PubMed Central* 2,160 606 2,766
Totals 12,218 2,313 14,531
*Since 14 November 2011
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar